Live Feeds
● TRACKER Updated 8d ago · 22 sources tracked

Second Quarter 2026 Financial Results

Multiple companies, including Arvinas, Innoviva, Standard BioTools, SiTime, Ero Copper, Dauch, AIxCrypto Holdings, Treace Medical Concepts, Rapid Micro Biosystems, and Tucows, have reported their second quarter 2026 financial results, showcasing various performances amid regional tensions and business model resilience.

RSS Source map (22)

What changed

More companies have reported their second quarter 2026 financial results, providing a clearer picture of the current business landscape.

Live updates

  1. Several Companies Report Second Quarter 2026 Financial Results

    Multiple companies, including Arvinas, Innoviva, Standard BioTools, SiTime, Ero Copper, Dauch, AIxCrypto Holdings, Treace Medical Concepts, Rapid Micro Biosystems, and Tucows, have reported their second quarter 2026 financial results, showcasing various performances amid regional tensions and business model resilience.

    Why it matters

    The second quarter 2026 financial results have been a mixed bag for various companies across different sectors. While some have reported positive results, others have faced challenges. The reports come amid regional tensions and economic uncertainty.

    What is confirmed

    • Arvinas secured the first regulatory approval for a PROTAC, VEPPANU.
    • Arvinas completed an out-licensing deal with Rigel Pharmaceuticals.
    • Boursa Kuwait recorded a net profit of KD 13.74mln for the first half of 2026.
    • Rapid Micro Biosystems reported second quarter 2026 total revenue of $8.1 million.
    • Rapid Micro Biosystems achieved 11% growth compared to the second quarter of 2025.
    • Tucows Inc. posted solid results in the second quarter 2026.

    Still unconfirmed

    • Strategy reported an 8.2 billion dollar loss.

    What to watch next

    • Upcoming financial reports from other companies
    • Merck MilliporeSigma to host European Growth Direct Day in October 2026
    • Full year 2026 guidance updates from Rapid Micro Biosystems
    Sources used for this update (16)
    1. www.aol.com — Dave Reports Second Quarter 2026 Financial Results
    2. www.aol.com — Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress
    3. www.manilatimes.net — Standard BioTools Reports Second Quarter 2026 Financial Results
    4. www.manilatimes.net — SiTime Reports Second Quarter 2026 Financial Results
    5. www.thespec.com — Ero Copper Reports Second Quarter 2026 Operating and Financial Results
    6. www.aol.com — Dauch Reports Second Quarter 2026 Financial Results
    7. www.aol.com — AIxCrypto Holdings Reports Second Quarter 2026 Results
    8. www.manilatimes.net — Treace Medical Concepts Reports Second Quarter 2026 Financial Results
    9. www.manilatimes.net — Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results
    10. www.finanznachrichten.de — Tucows Inc.: Tucows Posts Solid Results in Second Quarter 2026
    11. www.finanznachrichten.de — Faraday Copper Corp.: Faraday Copper Reports Second Quarter 2026 Financial Results
    12. www.newswire.ca — McCOY GLOBAL ANNOUNCES SECOND QUARTER 2026 RESULTS
    confidence 90%

  2. Arvinas and Boursa Kuwait Report Q2 2026 Financial Gains

    Arvinas and Boursa Kuwait reported positive results for the second quarter of 2026. Arvinas secured the first regulatory approval for a PROTAC, VEPPANU, and completed an out-licensing deal with Rigel Pharmaceuticals. Boursa Kuwait recorded a net profit of KD 13.74mln for the first half of 2026, attributing the result to the resilience of its business model amid regional tensions. These gains contrast with previous reports of an 8.2 billion dollar loss for Strategy and a cautious outlook from Stellantis.

    Why it matters

    Public companies are currently releasing financial data for the period ending June 2026. These reports highlight a mix of regulatory breakthroughs in biotechnology and financial stability in regional markets. The timing coincides with ongoing volatility in cryptocurrency and automotive sectors.

    What is confirmed

    • Boursa Kuwait recorded a net profit of KD 13.74mln in the first half of 2026.
    • Arvinas secured the first regulatory approval of a PROTAC, VEPPANU.
    • Arvinas completed out-licensing of VEPPANU to Rigel Pharmaceuticals.

    What to watch next

    • Intensity Therapeutics financial results announcement on August 11, 2026
    Sources used for this update (4)
    1. www.zawya.com — Boursa Kuwait records net profit of KD 13.74mln in the first half of 2026
    2. www.aol.com — Cat Financial Reports Second-Quarter 2026 Results
    3. www.aol.com — Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026
    4. www.manilatimes.net — Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update
    confidence 100%

  3. Stellantis and Strategy Report Divergent Q2 2026 Financial Results

    Stellantis returned to profit in the second quarter of 2026, fueled by a rebound in North American demand and operating income that more than tripled. Despite the profit swing and a jump in sales, the company only reaffirmed its full-year guidance, and its shares fell 5%. Meanwhile, Strategy reported an 8.2 billion dollar loss for the quarter due to declining bitcoin prices, though it remains the largest institutional holder of the cryptocurrency globally with 843,775 bitcoin.

    Why it matters

    Stellantis manages a diverse portfolio including Jeep and Ram, facing regional disparities as Europe remains unprofitable. Strategy's financial health is tied closely to the volatility of the bitcoin market. These results highlight the differing impacts of consumer demand and asset pricing on global corporate earnings.

    What is confirmed

    • Stellantis returned to profit in the second quarter of 2026.
    • Stellantis operating income more than tripled in Q2, driven by North America.
    • Stellantis shares fell 5% following the earnings report.
    • Strategy reported an 8.2 billion dollar loss in Q2 amid a decline in bitcoin prices.
    • Strategy holds 843,775 bitcoin, making it the largest institutional holder globally.
    • Balchem Corporation reported net sales of 284.0 million dollars and net earnings of 44.6 million dollars for the quarter ended June 30, 2026.

    Still unconfirmed

    • Stellantis earnings disappointed investors, leading to the share price skid.
    • Europe remains in the red for Stellantis.

    What to watch next

    • Sohu.com financial results report on August 10, 2026
    • Updated full-year guidance from Stellantis
    • Bitcoin price movements affecting Strategy liquidity
    Sources used for this update (16)
    1. Stellantis.com — Second Quarter 2026 Financial Results
    2. Reuters — Stellantis operating income more than triples in Q2, driven by North America
    3. CNBC — Jeep maker Stellantis swings to profit on rising demand in North America; shares fall 5%
    4. WSJ — Stellantis Shares Skid as Earnings Disappoint
    5. Yahoo Finance — Ram, Jeep parent Stellantis reports profit and sales jump, but only reaffirms full-year guidance
    6. autonews.com — Stellantis returns to profit in Q2 with North America rebound — Europe remains in the red
    7. Business Wire — Strategy Announces Second Quarter Financial Results; Currently Holds 843,775 Bitcoin; Now the Largest Institutional Holder Globally
    8. Yahoo Finance — Should You Buy, Sell or Hold MSTR Stock Before Q2 Earnings?
    9. Bloomberg.com — Strategy Shores Up Liquidity as Faithful Wait on Rebound
    10. CoinDesk — Strategy (MSTR) news: books $8.2 billion in Q2 loss amid bitcoin (BTC) price decline
    11. www.aol.com — GigaMedia Announces Second-Quarter 2026 Financial Results
    12. consent.yahoo.com — Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
    confidence 95%

  4. Stellantis and Balchem Report Q2 2026 Results

    Stellantis returned to profit in the second quarter of 2026, driven by a rebound in North American demand and a tripling of operating income. Despite the profit swing and sales growth, the company only reaffirmed its full-year guidance, and shares fell 5% as earnings disappointed some investors. Meanwhile, Balchem Corporation reported net sales of $284.0 million and net earnings of $44.6 million for the period ending June 30, 2026. Strategy reported a $8.2 billion Q2 loss due to declining bitcoin prices despite holding 843,775 Bitcoin.

    Why it matters

    The divergence in Stellantis' performance highlights a regional split where North American growth offsets losses in Europe. Strategy's results reflect the volatility of institutional bitcoin holdings. Balchem's figures provide a baseline for its fiscal second quarter performance.

    What is confirmed

    • Stellantis returned to profit in the second quarter of 2026.
    • North American demand drove a tripling of operating income for Stellantis in Q2.
    • Stellantis shares fell 5% following its earnings report.
    • Balchem Corporation reported net sales of $284.0 million and net earnings of $44.6 million for the quarter ended June 30, 2026.
    • Strategy holds 843,775 Bitcoin, making it the largest institutional holder globally.
    • Strategy recorded a $8.2 billion loss in Q2 amid a decline in bitcoin prices.

    Still unconfirmed

    • Europe remains in the red for Stellantis.

    What to watch next

    • Sohu.com financial results report on August 10, 2026
    • Updated full-year guidance from Stellantis
    Sources used for this update (16)
    1. Stellantis.com — Second Quarter 2026 Financial Results
    2. Reuters — Stellantis operating income more than triples in Q2, driven by North America
    3. CNBC — Jeep maker Stellantis swings to profit on rising demand in North America; shares fall 5%
    4. WSJ — Stellantis Shares Skid as Earnings Disappoint
    5. Yahoo Finance — Ram, Jeep parent Stellantis reports profit and sales jump, but only reaffirms full-year guidance
    6. autonews.com — Stellantis returns to profit in Q2 with North America rebound — Europe remains in the red
    7. Business Wire — Strategy Announces Second Quarter Financial Results; Currently Holds 843,775 Bitcoin; Now the Largest Institutional Holder Globally
    8. Yahoo Finance — Should You Buy, Sell or Hold MSTR Stock Before Q2 Earnings?
    9. Bloomberg.com — Strategy Shores Up Liquidity as Faithful Wait on Rebound
    10. CoinDesk — Strategy (MSTR) news: books $8.2 billion in Q2 loss amid bitcoin (BTC) price decline
    11. www.aol.com — GigaMedia Announces Second-Quarter 2026 Financial Results
    12. consent.yahoo.com — Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
    confidence 90%